YAKULT HONSHA CO.,LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,058 JPY | -0.62% |
|
+1.90% | -3.44% |
| Sales 2024 * | 506B 3.23B | Sales 2025 * | 519B 3.31B | Capitalization | 942B 6.01B |
|---|---|---|---|---|---|
| Net income 2024 * | 50.94B 325M | Net income 2025 * | 52.76B 337M | EV / Sales 2024 * | 1.54 x |
| Net cash position 2024 * | 162B 1.03B | Net cash position 2025 * | 183B 1.17B | EV / Sales 2025 * | 1.46 x |
| P/E ratio 2024 * |
18.6
x | P/E ratio 2025 * |
17.8
x | Employees | 29,880 |
| Yield 2024 * |
1.79% | Yield 2025 * |
1.86% | Free-Float | 71.96% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.62% | ||
| 1 week | +2.67% | ||
| Current month | -1.96% | ||
| 1 month | -1.70% | ||
| 3 months | -4.76% | ||
| 6 months | -12.85% | ||
| Current year | -3.44% |
1 week
3 023.00
3 115.00
1 month
2 920.503 152.00
Current year
2 920.503 334.00
1 year
2 920.505 215.00
3 years
2 630.005 215.00
5 years
2 407.505 215.00
10 years
2 252.505 215.00
| Managers | Title | Age | Since |
|---|---|---|---|
Hiroshi Narita
PSD | President | 72 | 74-03-31 |
| Chief Administrative Officer | 72 | 77-03-31 | |
Hideaki Hoshiko
BRD | Director/Board Member | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ryuji Yasuda
BRD | Director/Board Member | 78 | 09-05-31 |
Akinori Abe
AUD | Comptroller/Controller/Auditor | 72 | 74-03-31 |
| Chief Administrative Officer | 72 | 77-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 6.15% | 14 M€ | +8.46% | ||
| 0.51% | 15 M€ | +14.10% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 3,058 | -0.62% | 1 127 500 |
| 24-04-25 | 3,077 | -0.23% | 762,200 |
| 24-04-24 | 3,084 | -0.55% | 1,066,000 |
| 24-04-23 | 3,101 | 0.00% | 1,159,600 |
| 24-04-22 | 3,101 | +4.11% | 1,989,400 |
Delayed Quote Japan Exchange, April 26, 2024 at 02:00 am EDT
More quotes
YAKULT HONSHA CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of dairy products and pharmaceuticals. The Company operates in three business segments. The Beverages and Food Manufacturing and Sale segment is engaged in the manufacture and sale of dairy products, beverages, noodles and healthy food, the purchase and sale of materials, as well as the transportation business. The Company operates business in Japan, the Americas, Europe, Asia and Oceania. The Pharmaceuticals Manufacturing and Sale segment is engaged in the manufacture and sale of anticancer drugs and other ethical drugs. The Others segment is engaged in the production and sale of cosmetics, as well as the operation of professional baseball clubs.
Sector
Food Processing
Calendar
2024-05-13
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
3,077
JPY
Average target price
3,529
JPY
Spread / Average Target
+14.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.44% | 6.06B | |
| -2.25% | 95.24B | |
| +3.76% | 46.64B | |
| +0.75% | 40.77B | |
| +9.58% | 40.3B | |
| +0.38% | 38.22B | |
| -15.54% | 30.61B | |
| -6.49% | 29.66B | |
| +13.81% | 25.09B | |
| -10.87% | 22.26B |
- Stock Market
- Equities
- 2267 Stock
